66915 NEW YORK LIFE INSURANCE COMPANY PrintBooks Statement

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

ASSETS

1. Bonds (Schedule D)

2. Stocks (Schedule D):

2.1 Preferred stocks

2.2 Common stocks

3. Mortgage loans on real estate (Schedule B):

3.1 First liens

3.2 Other than first liens

4. Real estate (Schedule A):

4.1 Properties occupied by the company (less $

encumbrances)

4.2 Properties held for the production of income (less

$

(340,825,713) encumbrances)

4.3 Properties held for sale (less $

encumbrances)

5. Cash ($

(174,427,028) , Schedule E - Part 1), cash equivalents

($

2,993,820,782 , Schedule E - Part 2) and short-term

investments ($

15,621,072 , Schedule DA)

6. Contract loans (including $

0 premium notes)

7. Derivatives (Schedule DB)

8. Other invested assets (Schedule BA)

9. Receivables for securities

10. Securities lending reinvested collateral assets (Schedule DL)

11. Aggregate write-ins for invested assets

12. Subtotals, cash and invested assets (Lines 1 to 11)

13. Title plants less $

charged off (for Title insurers

only)

14. Investment income due and accrued

15. Premiums and considerations:

15.1 Uncollected premiums and agents' balances in the course of collection

15.2 Deferred premiums and agents' balances and installments booked but

deferred and not yet due (including $

earned but unbilled premiums)

15.3 Accrued retrospective premiums ($

) and

contracts subject to redetermination ($

)

16. Reinsurance:

16.1 Amounts recoverable from reinsurers

16.2 Funds held by or deposited with reinsured companies

16.3 Other amounts receivable under reinsurance contracts

17. Amounts receivable relating to uninsured plans

18.1 Current federal and foreign income tax recoverable and interest thereon

18.2 Net deferred tax asset

19. Guaranty funds receivable or on deposit

20. Electronic data processing equipment and software

21. Furniture and equipment, including health care delivery assets

($

)

22. Net adjustment in assets and liabilities due to foreign exchange rates

23. Receivables from parent, subsidiaries and affiliates

24. Health care ($

) and other amounts receivable

25. Aggregate write-ins for other than invested assets

26. Total assets excluding Separate Accounts, Segregated Accounts and Protected Cell Accounts (Lines 12 to 25)

27. From Separate Accounts, Segregated Accounts and Protected Cell Accounts

28. Total (Lines 26 and 27)

1

Assets

106,076,790,232

Current Year 2

Nonadmitted Assets

3 Net Admitted Assets

(Cols. 1 - 2)

106,076,790,232

65,090,535 10,252,633,292

65,090,535 10,252,633,292

16,456,480,729 1,097,123,538

16,456,480,729 1,097,123,538

265,375,273 1,220,481,846

163,200

265,375,273 1,220,481,846

163,200

2,835,014,826 11,210,150,479

648,426,440 9,674,059,981

3,191,281

86,646,519 159,891,628,171

1,653,964 93,369,985

95,023,949

2,835,014,826 11,208,496,515

648,426,440 9,580,689,996

3,191,281

86,646,519 159,796,604,222

1,493,738,685 227,661,883

5,545,755

1,493,738,685 222,116,128

1,715,454,825

1,715,454,825

50,681,889 20,937,397

50,681,889 20,937,397

1,490,774,176 5,640,695

449,494,576

208,814,436

70,680,131 31,861,282 5,444,265,791

171,101,633,937

10,453,433,567 181,555,067,504

414,546,771 208,814,436

31,861,282 763,050,934 1,518,843,127

1,518,843,127

1,490,774,176 5,640,695 34,947,805

70,680,131 4,681,214,857 169,582,790,810 10,453,433,567 180,036,224,377

DETAILS OF WRITE-INS

1101. 1102. 1103. 1198. 1199. 2501. 2502. 2503. 2598. 2599.

Derivatives-collateral assets Investment receivable

Summary of remaining write-ins for Line 11 from overflow page Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above)

Amounts receivable on corporate owned life insurance Interest in annuity contracts Unearned reinsurance premium recoverable

Summary of remaining write-ins for Line 25 from overflow page Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above)

86,646,519

86,646,519

86,646,519 4,390,318,240

145,260,205 76,750,068 831,937,278 5,444,265,791

763,050,934 763,050,934

86,646,519 4,390,318,240

145,260,205 76,750,068 68,886,344 4,681,214,857

Prior Year 4

Net Admitted Assets

98,176,054,937

70,678,440 10,736,656,403

14,530,685,038 1,145,044,201

246,446,127

1,277,706,426

215,968

2,420,436,061 10,876,789,036

586,797,630 9,456,949,169

16,265,272

95,188,134 149,635,912,842

1,285,130,050

260,513,581

1,689,713,482

19,226,586 4,014,885,328

29,688,665

386,917,534 1,092,975,561

7,247,807 26,632,690

322,196,590

4,640,725,508 163,411,766,224 13,353,781,465 176,765,547,689

94,743,808 444,326

95,188,134 4,343,004,085

149,260,246 73,554,597 74,906,580 4,640,725,508

2

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

LIABILITIES, SURPLUS AND OTHER FUNDS

1. Aggregate reserve for life contracts $

105,378,661,292 (Exh. 5, Line 9999999) less $

included in Line 6.3 (including $

449,330,686 Modco Reserve)

2. Aggregate reserve for accident and health contracts (including $

503,177,819 Modco Reserve)

3. Liability for deposit-type contracts (Exhibit 7, Line 14, Col. 1) (including $

Modco Reserve)

4. Contract claims:

4.1 Life (Exhibit 8, Part 1, Line 4.4, Col. 1 less sum of Cols. 9, 10 and 11)

4.2 Accident and health (Exhibit 8, Part 1, Line 4.4, sum of Cols. 9, 10 and 11)

5. Policyholders' dividends $

21,786,543 and coupons $

due and unpaid (Exhibit 4,

Line 10)

6. Provision for policyholders' dividends and coupons payable in following calendar year - estimated amounts:

6.1 Dividends apportioned for payment (including $

132,777 Modco)

6.2 Dividends not yet apportioned (including $

Modco)

6.3 Coupons and similar benefits (including $

Modco)

7. Amount provisionally held for deferred dividend policies not included in Line 6

8. Premiums and annuity considerations for life and accident and health contracts received in advance less

$

70,405 discount; including $

1,894,248 accident and health premiums (Exhibit 1,

Part 1, Col. 1, sum of lines 4 and 14)

9. Contract liabilities not included elsewhere:

9.1 Surrender values on canceled contracts

9.2 Provision for experience rating refunds, including the liability of $

accident and health

experience rating refunds of which $

is for medical loss ratio rebate per the Public Health

Service Act 9.3 Other amounts payable on reinsurance, including $

ceded 9.4 Interest maintenance reserve (IMR, Line 6)

36,290,000 assumed and $

5,376,292

10. Commissions to agents due or accrued-life and annuity contracts $

15,560,166 accident and health

$

3,455,674 and deposit-type contract funds $

11. Commissions and expense allowances payable on reinsurance assumed

12. General expenses due or accrued (Exhibit 2, Line 12, Col. 6)

13. Transfers to Separate Accounts due or accrued (net) (including $

0 accrued for expense

allowances recognized in reserves, net of reinsured allowances)

14. Taxes, licenses and fees due or accrued, excluding federal income taxes (Exhibit 3, Line 9, Col. 5)

15.1 Current federal and foreign income taxes, including $

0 on realized capital gains (losses)

15.2 Net deferred tax liability

16. Unearned investment income

17. Amounts withheld or retained by company as agent or trustee

18. Amounts held for agents' account, including $

32,199,660 agents' credit balances

19. Remittances and items not allocated

20. Net adjustment in assets and liabilities due to foreign exchange rates

21. Liability for benefits for employees and agents if not included above

22. Borrowed money $

500,534,271 and interest thereon $

0

23. Dividends to stockholders declared and unpaid

24. Miscellaneous liabilities:

24.01 Asset valuation reserve (AVR, Line 16, Col. 7)

24.02 Reinsurance in unauthorized and certified ($

) companies

24.03 Funds held under reinsurance treaties with unauthorized and certified ($ 24.04 Payable to parent, subsidiaries and affiliates 24.05 Drafts outstanding 24.06 Liability for amounts held under uninsured plans

) reinsurers

24.07 Funds held under coinsurance

24.08 Derivatives 24.09 Payable for securities 24.10 Payable for securities lending 24.11 Capital notes $

and interest thereon $

25. Aggregate write-ins for liabilities

26. Total liabilities excluding Separate Accounts business (Lines 1 to 25)

27. From Separate Accounts Statement

28. Total liabilities (Lines 26 and 27)

29. Common capital stock

30. Preferred capital stock 31. Aggregate write-ins for other than special surplus funds 32. Surplus notes 33. Gross paid in and contributed surplus (Page 3, Line 33, Col. 2 plus Page 4, Line 51.1, Col. 1)

34. Aggregate write-ins for special surplus funds

35. Unassigned funds (surplus)

36. Less treasury stock, at cost:

36.1

shares common (value included in Line 29 $

)

36.2

shares preferred (value included in Line 30 $

)

37. Surplus (Total Lines 31+32+33+34+35-36) (including $ 38. Totals of Lines 29, 30 and 37 (Page 4, Line 55)

0 in Separate Accounts Statement)

39. Totals of Lines 28 and 38 (Page 2, Line 28, Col. 3)

2501. 2502. 2503. 2598. 2599.

DETAILS OF WRITE-INS

Special reserves on certain group policies Unfunded pension obligations for employees and agents Derivatives-collateral liability

Summary of remaining write-ins for Line 25 from overflow page Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above)

3101. 3102. 3103. 3198.

Summary of remaining write-ins for Line 31 from overflow page

3199. Totals (Lines 3101 thru 3103 plus 3198)(Line 31 above)

3401. 3402.

3403.

3498. Summary of remaining write-ins for Line 34 from overflow page 3499. Totals (Lines 3401 thru 3403 plus 3498)(Line 34 above)

1 Current Year

105,378,661,292 4,137,322,339 21,908,898,645

718,673,049 28,494,049

21,786,543

1,889,118,718

97,743,779

41,666,292 534,590,044

19,015,840 3,784,000 2,065,155,417

2,162,776 29,209,446 40,671,969

580,299 1,116,692,470

32,199,660 254,116,621 34,030,962 338,139,997 500,534,271

2,593,993,510 3,710,856

32,568,668

4,047,937,587 342,123,114 104,299,843 652,922,650

1,605,515,738 148,576,320,444 10,453,433,567 159,029,754,011

1,993,633,128

19,012,837,238

21,006,470,366 21,006,470,366 180,036,224,377

447,425,937 367,376,067 321,060,668 469,653,066 1,605,515,738

2 Prior Year

103,309,080,415 3,892,245,008 17,922,307,444

761,892,659 23,954,707

23,911,076

1,873,399,765

91,084,956

29,349,017

53,157,625 657,538,647

17,784,844 14,281,763 2,027,669,145

4,321,707 22,074,474 2,138,904

2,193,540 1,054,531,210

29,616,147 282,029,077 26,614,626 363,041,001 496,476,848

2,651,609,526 1,144,062

37,051,781

4,227,539,196 322,903,145 323,355,607 678,959,507

1,831,558,399 143,054,815,828 13,353,781,465 156,408,597,293

1,993,230,795

18,363,719,601

20,356,950,396 20,356,950,396 176,765,547,689

345,527,386 574,171,210 328,700,964 583,158,839 1,831,558,399

3

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

SUMMARY OF OPERATIONS

1. Premiums and annuity considerations for life and accident and health contracts (Exhibit 1, Part 1, Line 20.4, Col. 1, less Col. 11)

2. Considerations for supplementary contracts with life contingencies

3. Net investment income (Exhibit of Net Investment Income, Line 17)

4. Amortization of Interest Maintenance Reserve (IMR, Line 5)

5. Separate Accounts net gain from operations excluding unrealized gains or losses

6. Commissions and expense allowances on reinsurance ceded (Exhibit 1, Part 2, Line 26.1, Col. 1)

7. Reserve adjustments on reinsurance ceded

8. Miscellaneous Income:

8.1 Income from fees associated with investment management, administration and contract guarantees from Separate Accounts

8.2 Charges and fees for deposit-type contracts

8.3 Aggregate write-ins for miscellaneous income

9. Total (Lines 1 to 8.3)

10. Death benefits

11. Matured endowments (excluding guaranteed annual pure endowments)

12. Annuity benefits (Exhibit 8, Part 2, Line 6.4, Cols. 4 + 8)

13. Disability benefits and benefits under accident and health contracts

14. Coupons, guaranteed annual pure endowments and similar benefits

15. Surrender benefits and withdrawals for life contracts

16. Group conversions

17. Interest and adjustments on contract or deposit-type contract funds

18. Payments on supplementary contracts with life contingencies

19. Increase in aggregate reserves for life and accident and health contracts

20. Totals (Lines 10 to 19)

21. Commissions on premiums, annuity considerations, and deposit-type contract funds (direct business only) (Exhibit 1, Part 2, Line 31, Col. 1)

22. Commissions and expense allowances on reinsurance assumed (Exhibit 1, Part 2, Line 26.2, Col. 1)

23. General insurance expenses (Exhibit 2, Line 10, Cols. 1, 2, 3 and 4)

24. Insurance taxes, licenses and fees, excluding federal income taxes (Exhibit 3, Line 7, Cols. 1 + 2 + 3)

25. Increase in loading on deferred and uncollected premiums

26. Net transfers to or (from) Separate Accounts net of reinsurance

27. Aggregate write-ins for deductions

28. Totals (Lines 20 to 27)

29. Net gain from operations before dividends to policyholders and federal income taxes (Line 9 minus Line 28)

30. Dividends to policyholders

31. Net gain from operations after dividends to policyholders and before federal income taxes (Line 29 minus Line 30)

32. Federal and foreign income taxes incurred (excluding tax on capital gains)

33. Net gain from operations after dividends to policyholders and federal income taxes and before realized capital gains or (losses) (Line 31 minus Line 32)

34. Net realized capital gains (losses) (excluding gains (losses) transferred to the IMR) less capital gains tax of

$

(28,886,725) (excluding taxes of $

(5,914,372) transferred to the IMR)

35. Net income (Line 33 plus Line 34)

CAPITAL AND SURPLUS ACCOUNT

36. Capital and surplus, December 31, prior year (Page 3, Line 38, Col. 2)

37. Net income (Line 35)

38. Change in net unrealized capital gains (losses) less capital gains tax of $

13,086,272

39. Change in net unrealized foreign exchange capital gain (loss)

40. Change in net deferred income tax

41. Change in nonadmitted assets

42. Change in liability for reinsurance in unauthorized and certified companies

43. Change in reserve on account of change in valuation basis, (increase) or decrease

44. Change in asset valuation reserve

45. Change in treasury stock (Page 3, Lines 36.1 and 36.2, Col. 2 minus Col. 1)

46. Surplus (contributed to) withdrawn from Separate Accounts during period

47. Other changes in surplus in Separate Accounts Statement

48. Change in surplus notes

49. Cumulative effect of changes in accounting principles

50. Capital changes:

50.1 Paid in

50.2 Transferred from surplus (Stock Dividend)

50.3 Transferred to surplus

51. Surplus adjustment:

51.1 Paid in

51.2 Transferred to capital (Stock Dividend)

51.3 Transferred from capital

51.4 Change in surplus as a result of reinsurance

52. Dividends to stockholders

53. Aggregate write-ins for gains and losses in surplus

54. Net change in capital and surplus for the year (Lines 37 through 53)

55. Capital and surplus, December 31, current year (Lines 36 + 54) (Page 3, Line 38)

DETAILS OF WRITE-INS

08.301. Sundries 08.302. Adjustment in funds withheld

08.303.

08.398. Summary of remaining write-ins for Line 8.3 from overflow page

08.399. Totals (Lines 08.301 thru 08.303 plus 08.398)(Line 8.3 above)

2701. Adjustment in funds withheld 2702. Change in special reserves on certain group policies 2703. Interest on benefit plans for employees and agents

2798. Summary of remaining write-ins for Line 27 from overflow page

2799. Totals (Lines 2701 thru 2703 plus 2798)(Line 27 above)

5301. Change in overfunded pension plan asset 5302. Change in liability for pension benefits 5303. Change in liability for postretirement benefits

5398. Summary of remaining write-ins for Line 53 from overflow page

5399. Totals (Lines 5301 thru 5303 plus 5398)(Line 53 above)

1 Current Year

17,084,340,532 817,722

7,234,101,063 103,636,530

36,025,357 (91,433,574)

35,374,913 37,780,323 (3,810,779,938) 20,629,862,928 3,939,870,210 17,948,714 1,279,577,153 256,554,689

7,885,886,698 18,744,041 476,034,332 6,401,690

2,079,033,291 15,960,050,818

507,865,282 39,829,966 2,496,849,460 246,836,997 (4,320,654) (1,706,085,016) 271,272,123 17,812,298,976 2,817,563,952 1,974,316,854 843,247,098 (441,825,325)

1,285,072,423

(74,713,710) 1,210,358,713

20,356,950,396 1,210,358,713 (500,467,242)

(49,884,679) (92,922,231) (208,995,148) (2,566,793) (235,624,931) 57,616,016

402,333

471,603,932 649,519,970 21,006,470,366

75,122,530 (3,885,902,468)

(3,810,779,938) 149,179,520 101,898,550 10,259,103 9,934,950 271,272,123 225,655,857 206,795,143 41,243,651 (2,090,719) 471,603,932

2 Prior Year

15,070,047,907 928,840

6,603,475,767 104,765,354

35,359,752 (70,849,471)

12,048,147 72,209,702 505,267,141 22,333,253,139 3,944,277,989 17,890,571 1,215,286,229 241,353,325

6,548,627,203 19,252,233 364,858,711 4,052,862

4,600,376,591 16,955,975,714

488,358,468 105,023,091 2,338,094,448 230,759,103

7,653,355 (981,483,203) 281,918,542 19,426,299,518 2,906,953,621 1,958,311,333 948,642,288 (622,079,846)

1,570,722,134

(90,858,697) 1,479,863,437

20,107,561,106 1,479,863,437

896,067,511 (53,350,746) (1,522,871,560) 412,892,521

1,304,576 (313,809,431) (476,142,030)

(8,050,052) (5,874,558)

402,333

(161,042,710) 249,389,291 20,356,950,396

316,760,396 188,506,745

505,267,141 157,706,789 38,846,137 67,491,838 17,873,778 281,918,542 (701,788,305) 636,769,457 (94,204,889) (1,818,973) (161,042,710)

4

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

CASH FLOW

1

2

Cash from Operations

1. Premiums collected net of reinsurance

2. Net investment income

3. Miscellaneous income

4. Total (Lines 1 through 3)

5. Benefit and loss related payments

6. Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts

7. Commissions, expenses paid and aggregate write-ins for deductions

8. Dividends paid to policyholders

9. Federal and foreign income taxes paid (recovered) net of $

13,667,446 tax on capital gains (losses)

10. Total (Lines 5 through 9)

11. Net cash from operations (Line 4 minus Line 10)

Current Year

Prior Year

17,086,835,311 6,300,993,097

248,841,013 23,636,669,421 13,672,729,169 (1,702,385,477) 2,747,644,933 1,963,744,030

(862,800,466) 15,818,932,189 7,817,737,232

14,996,705,331 6,232,706,103

448,595,007 21,678,006,441 12,219,315,598

(991,191,870) 2,684,601,461 1,938,012,180 (196,823,590) 15,653,913,779 6,024,092,662

Cash from Investments 12. Proceeds from investments sold, matured or repaid:

12.1 Bonds 12.2 Stocks 12.3 Mortgage loans 12.4 Real estate 12.5 Other invested assets 12.6 Net gains or (losses) on cash, cash equivalents and short-term investments 12.7 Miscellaneous proceeds 12.8 Total investment proceeds (Lines 12.1 to 12.7) 13. Cost of investments acquired (long-term only): 13.1 Bonds 13.2 Stocks 13.3 Mortgage loans 13.4 Real estate 13.5 Other invested assets 13.6 Miscellaneous applications 13.7 Total investments acquired (Lines 13.1 to 13.6) 14. Net increase (decrease) in contract loans and premium notes 15. Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14)

14,093,937,742 1,150,532,049 1,986,556,844

181,716,102 1,549,290,000

297,142 10,374,118 18,972,703,997

13,202,303,882 1,119,787,457 1,679,532,270

27,837,770 1,308,062,695

2,989,180 (192,223,300) 17,148,289,954

21,839,619,964 1,253,547,697 3,880,701,427

24,892,865 1,959,974,677

209,643,186 29,168,379,816

332,014,846 (10,527,690,665)

17,658,795,303 1,331,982,436 2,542,208,714

401,081,096 1,545,450,864

23,479,518,413 280,523,405

(6,611,751,864)

Cash from Financing and Miscellaneous Sources 16. Cash provided (applied):

16.1 Surplus notes, capital notes 16.2 Capital and paid in surplus, less treasury stock 16.3 Borrowed funds 16.4 Net deposits on deposit-type contracts and other insurance liabilities

16.5 Dividends to stockholders 16.6 Other cash provided (applied) 17. Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6)

4,057,423 3,729,110,300

(6,751,150) 1,106,334,825

(608,635,525) 3,124,532,198

(1,080,442,304) 19,141,371

RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

18. Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)

19. Cash, cash equivalents and short-term investments:

19.1 Beginning of year

19.2 End of year (Line 18 plus Line 19.1)

Note: Supplemental disclosures of cash flow information for non-cash transactions:

20.0001. Transfer/exchange of bond investment to bond investment 20.0002. Depreciation/amortization on fixed assets 20.0003. Transfer of other invested assets to real estate 20.0004. Transfer between other invested assets 20.0005. Capitalized interest on bonds/payment in kind 20.0006. Transfer of equity to charitable organizations 20.0007. Transfer of bonds to other invested assets 20.0008. Capital contribution to affiliated other invested asset 20.0009. Merger/spinoff/exchange/conversion/transfer of equity investment to equity investment 20.0010. Exchange/conversion of bond investment to equity investment 20.0011. Low income housing tax credit future commitments 20.0012. Other invested assets stock distribution 20.0013. Transfer of bond to short term investment

414,578,765

2,420,436,061 2,835,014,826

(568,517,831)

2,988,953,892 2,420,436,061

733,440,659 202,640,520 158,124,184 142,224,663 115,179,362 100,001,341 86,590,903 37,608,758 26,778,594 16,619,167

9,412,579 3,571,164 3,466,929

651,783,750 154,259,173

128,529,986 114,999,323 15,000,117 27,766,643

40,313,819 48,812,479 20,649,512 2,639,520

5

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

Note: Supplemental disclosures of cash flow information for non-cash transactions:

20.0014. Capitalized deferred interest on mortgage loans 20.0015. Dividend reinvestment of equities/payment in kind 20.0016. Transfer of equity investment to other invested asset 20.0017. Transfer from real estate to other invested assets 20.0018. Bond to be announced commitments-purchased/sold 20.0019. Transfer of mortgage loan to other invested assets 20.0020. Dividend distribution from affiliated other invested asset

1,494,914 602,300 321,758

20,164,865 172,204

392,536,599 212,038,773 38,188,318

9,843,881

5.1

%&

5 $. !.( # % #%(

! % # ( $ % ( ) & )$

## $ % '$ &%'

5

( $ % ( ) (!""&$.$ % # % #%( 6 %' & )$ # % 3$ # $(

*5 $% ,$(%.$ % # .$

+5 . % 7 % ) %$ $(% %$ #$ $($ ,$ / 0

-5 $" %$ ## ! %( $% 3 ) . "$ % ( $8#&! 3 ! $ & 7$ 3 ( & (($(

5

.. (( ( $8"$ ($ && 6 #$( $ (! #$ #$ $

15 $($ ,$ 9!(%.$ %( $ (! #$ #$ $

5 (#$&& $ !( # .$:

5 $$( (( # %$ 6 %' # .$ ) . ,$(%.$ % . 3$.$ %;

. (% %

# % #% 3! %$$( ) . $" %$ ## ! %(

5 ' 3$( )$$( ) $" ( %$ $) %(

*5 = ( > & % >$ $) %( >$ $) %( ! $ ## $ % '$ &%' # % #%(

+5

!" (; 3! %$$ ! & "! $ $ 6.$ %( ( . & >$ $) %(

-5 ! $ $ >$ $) %( 6 %' 6 &( ) & )$ # % #%(

5

!" # ,$ ( (

15 %$ $(%

9!(%.$ %( # % #% $" ( %!( $(( & 0

$" ( %$) $ , $ ( % " & # ' & $ ( )$ $ & # .$ % 8$( / $ 2 . !( $ 0

* 5 =, $ (% " &# ' & $ (

* 5 $% 3 ) . "$ % ( )%$ , $ ( % " & # ' & $ ( >$) $ )$ $ & # .$ % 8$( / $ 2 . !( $ * 0

* 5 $ $ & # .$ % 8$( #! $ /$8#&! 3 % 8 # " % & 3 (0

**5 $% 3 ) . "$ % ( )%$ , $ ( % " & # ' & $ ( )$ $ & # .$ % 8$( >$) $ $ & 7$ # " % & 3 ( /& (($(0 / $ * . !( $ * 0

!(% & )$

* )$ (! #$

+ , ! & ! % $(

5* 5

5* 5

5* *5

5*2 5 !.. ) $. 3 6 %$< ( ) $ 5* ) . ,$ )& 6 " 3$

5*225 % &( / $( 5* %' ! 5* * "&!( 5*2 0 / $ 5* > ,$0

15

15

! "#

1 *5 &

%'

$ %#

! % " "% #

" % " %(

!

12 5 !.. ) $. 3 6 %$< ( ) $ 1 ) . ,$ )& 6 " 3$

1225

% &( / $( 1 %' ! 1 * "&!( 12 0 / $ 1 > ,$0

/ 0 #&! $( %'$ ) && 6 3 . ! %( )

?:

$

;$

;$

/LQH&ROXPQLQFOXGHVWUDQVIHUVQHWRIULVNFKDUJHVXQGHUFHUWDLQVHSDUDWHDFFRXQWFRQWUDFWVRI&XPXODWLYHWUDQVIHUVIURPLQFHSWLRQQHWRIULVNFKDUJHVDUH &RUUHVSRQGLQJDPRXQWVIRUFHUWDLQ6\QWKHWLF*,&FRQWUDFWVDUHLQDQGVLQFHLQFHSWLRQ

!""&$.$ %

% #%(

; $*

$ % )$ / !" , ! &0

!" 1 )$ (! #$ /0

; $+

! % $(

## $ %

$ &%'

2

$ % / !"

!"

, ! &0

%'$

33 $3 %$ ) && %'$ $( ) 4!( $((

ANNUAL STATEMENT FOR THE YEAR 2018 OF THE NEW YORK LIFE INSURANCE COMPANY

ANALYSIS OF INCREASE IN RESERVES DURING THE YEAR

1 Total

2 Industrial Life

3 Life Insurance

Ordinary 4

Individual Annuities

5 Supplementary

Contracts

6

Credit Life (Group and Individual)

Group 7

Life Insurance

8 Annuities

Involving Life or Disability Contingencies (Reserves)

(Net of Reinsurance Ceded)

7

1. Reserve December 31, prior year 2. Tabular net premiums or considerations 3. Present value of disability claims incurred 4. Tabular interest 5. Tabular less actual reserve released 6. Increase in reserve on account of change in valuation basis 6.1 Change in excess of VM-20 deterministic/stochastic reserve over net premium reserve 7. Other increases (net) 8. Totals (Lines 1 to 7) 9. Tabular cost 10. Reserves released by death 11. Reserves released by other terminations (net) 12. Annuity, supplementary contract and disability payments involving life contingencies 13. Net transfers to or (from) Separate Accounts 14. Total Deductions (Lines 9 to 13) 15. Reserve December 31, current year

103,309,080,416 15,677,205,246

21,987,453 4,164,814,769

(14,173,478) 38,876,289

XXX

(3,670,895,273) 119,526,895,422

4,291,294,131 1,285,262,762 2,404,755,192 6,791,518,788 (624,596,744) 14,148,234,129 105,378,661,293

75,711,880,573 7,086,187,976

21,239,639 2,962,137,850

1,869,867

8,424,540,298 243,869,657

434,395,632 (29,849,599)

10,582,414 752,304

XXX

260,469 4,888,393

XXX

XXX

XXX

(4,138,166,977)

200,000,000

81,645,148,929

9,272,955,988

16,483,580

3,325,025,547

XXX

1,138,022,229

XXX

XXX

2,223,189,739

1,205,185

37,151,186

540,519,528

6,401,690

6,723,388,701 74,921,760,228

541,724,713 8,731,231,275

6,401,690 10,081,890

3,120,444,682 1,366,349,808

747,814 141,197,317

2,357,296 32,876,289

XXX

288,499,710 4,952,472,916

966,268,584 147,240,533 180,360,268

6,756,920

1,300,626,305 3,651,846,611

16,041,632,449 6,980,045,500

626,823,500 6,560,565 6,000,000

XXX

(21,228,006) 23,639,834,009

XXX

6,200,689,464 (624,596,744) 5,576,092,720 18,063,741,289

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download